Cite

HARVARD Citation

    Brook, R. et al. (2017). Cardiovascular outcomes with an inhaled beta2-agonist/corticosteroid in patients with COPD at high cardiovascular risk. Heart. 103 (19), pp. 1536-1542. [Online]. 
  
Back to record